Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Domestic SB623 Chronic Traumatic Brain Injury Program (follow-up report)

Sun Bio Co., Ltd. came out (follow-up report) on 2024/6/20.
“After yesterday's headquarters meeting, it was determined that it is possible to approve the “Acugo Brain Transplantation Note” as an improvement treatment for chronic motor paralysis associated with traumatic brain injury after attaching approval conditions and deadlines. Based on the results of deliberation by the headquarters meeting, it is expected that the Ministry of Health, Labor, and Welfare will formally approve manufacturing and sales with conditions and deadlines in the future.”
I intended to buy it for 1,148 yen, but I can't believe I can buy it for 848 yen (26% off)...
Maybe... there are only people who don't understand insurance treatment? Do people who understand become insiders?
Is this a sale that understands what this means? I don't understand the investor mentality at all. Why are they being sold?
Is there anything I as an amateur don't understand at all? it's a strange world...
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
5
+0
6
See Original
Report
16K Views
Comment
Sign in to post a comment
  • ランディー12 : Well, it's an understandable sale.
    Both this approval and the last time it was postponed, this company did nothing about patients or shareholders.
    I don't even know why the Ministry of Health, Labor, and Welfare approved it with a deadline.
    7 years. I'm not good at it. If this is the case, it would be much better to proceed with the research as a clinical trial and complete it properly.

  • ランディー12 : Incidentally, I am a health care worker who was a shareholder of Sunbio until yesterday.

  • sleepinglion OP : The official announcement from the Ministry of Health, Labor, and Welfare is noteworthy.
    Until now, most of the pharmaceuticals that have been “approved with a time limit”... what happened?
    Unless you are involved in insurance treatment... you don't know...
    Well, how are people who are familiar with insurance treatment working...
    It is said that Randy is a health care worker, but is she a doctor?
    Aside from that, “the picture of the tower is so beautiful, isn't it?”

  • ランディー12 : I was disappointed with the press conference when approval was postponed last time
    I had no choice but to wait for stocks that had crashed to rise.

    Well, it's interesting.

    If you look it up, I think it will come up!

    How do people who are familiar with it move is about stocks?

    I'm not a doctor

    Thank you so much!

  • Sinq : It has been approved, but since stable quality cannot be maintained, it cannot be shipped.
    Simply put, you can't sell it.

  • sleepinglion OP : If it's a clinical trial, drug prices aren't included, right?
    If drug prices are added, you will feel the country's intention to pave the way for clinical practice.
    Drug price is included = you can try using it for treatment if you wish
    A long time ago, there was something called the Maruyama vaccine...
    As you know, mixed medical treatment is not possible with insurance treatment, with the exception of highly advanced medical care.
    I think that the fact that drug prices are attached means that there are a certain number of situations where advantages outweigh disadvantages.
    It seems like a god to patients who have obtained an effect, and patients who have had no effect will expect an increase in efficacy. I think the key to this system is to provide an environment where you can try using it...
    It's a pity that it can't be shipped

53Followers
0Following
188Visitors
Follow